Updated:
Colorectal Cancer Alliance
Colorectal Cancer Alliance: the largest US nonprofit fighting colorectal cancer through screening, research, and patient support.
Colorectal Cancer Alliance
The Colorectal Cancer Alliance was founded in 1999 as a patient advocacy organization, evolving into a research-and-support engine that allocates millions annually toward colorectal cancer initiatives. Its public-facing mission focuses on screening access and patient navigation. The Alliance deploys capital across prevention campaigns, research grants, and patient assistance programs. It funds studies into treatment efficacy and survivorship, and partners with academic medical centers to push detection rates. Its priority regions include the United States and select global health markets. Staff and volunteer advocates number in the hundreds. The organization runs the Blue Hope campaign and operates a patient navigation hotline. No recent operational events are documented in public records beyond routine annual grant cycles. As a 501(c)(3), the Alliance operates without an endowment or investment mandate, distinguishing it from for-profit health investors. Its board comprises medical professionals and patient advocates, not financial allocators.
General information
Firm type
Foundation
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park, Mountain View, Boston, Basel, Baltimore, Arlington, London, Washington, New York, Palo Alto, Los Altos, San Francisco, Atlanta, Oakland
Corporate office
United States
Sector focus
Frequently asked questions
What is the Colorectal Cancer Alliance's primary mission?
The Alliance focuses on reducing colorectal cancer incidence and mortality through screening access, patient support, and research funding. It does not manage a for-profit investment portfolio.
How does the Alliance deploy its financial resources?
Deployment flows through fundraising campaigns, grant programs for researchers, and direct patient assistance. Its budget is publicly disclosed in annual IRS filings.
Is the Colorectal Cancer Alliance a single-family office?
No. It is a 501(c)(3) public charity, not a family office. It raises funds from individuals, corporations, and foundations.
What investment vehicles does the Alliance use?
The Alliance does not operate investment funds. It uses a standard nonprofit financial model of operating reserves and donor-restricted funds.
Where is the Colorectal Cancer Alliance headquartered?
The organization maintains offices in several US cities including Arlington, VA, and Washington, DC. Its headquarters is listed in the United States.
Does the Alliance fund clinical trials?
Yes, it awards research grants for studies in screening, treatment, and survivorship. Recipients include academic institutions and medical centers.
Who leads the Colorectal Cancer Alliance?
The CEO as of public records is Michael Sapienza. The board includes clinicians and patient advocates. Exact details are available on the firm's Form 990.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: